DEMAREE JOHN 4
4 · G1 Therapeutics, Inc. · Filed Feb 7, 2020
Insider Transaction Report
Form 4
DEMAREE JOHN
Chief Commercial Officer
Transactions
- Award
Stock Options (Right to Buy)
2020-02-06+30,000→ 30,000 totalExercise: $21.08Exp: 2030-02-06→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest as to 25% of the shares on February 06, 2021, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.